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Atria1 natriuretic factor (ANF) and C-type natriuretic peptide (CNP)-activated guanylate cyclases are single-chain transmembrane-spanning 
proteins, containing both ligand binding and catalytic activities. In both proteins, ligand binding to the extracellular receptor domain activates the 
cytosolic catalytic domain, generating the second messenger cyclic GMP. Studies with ANF receptor guanylate cyclase (ANF-RGC) have indicated 
that obligatory in this activation process is an ATP-dependent step. ATP directly bmds to the cyclase and bridges the events of ligand binding and 
signal transduction. A defined ATP-regulated module (ARM) sequence (GlySo3-Arg-Gly-Ser-Asn-Tyr-Gly’? in the cyclase is critical in the 
ATP-mediated event. Through genetic remodeling techniques, we have now identified the core ARM sequence that is essential in both ANF and 
CNP signaling. This sequence is Gly-Xa-Xa-Xa-Gly, represented by Gly505-Ser-Asn-Tyr-Gly509 in the case of ANF-RGC ARM and by 
Gly499-Ser-Ser-Tyr-GlySO) in the CNP receptor guanylate cyclase ARM. 
Guanylate cyclase; ATP-regulatory module; Atria1 natriuretic factor receptor; Type C natriuretic peptide receptor 
1. INTRODUCTION main activates the cytosolic catalytic domain, generat- 
ing the second messenger cyclic GMP [2,16]. 
One important class of guanylate cyclases is that its Studies with ANF-RGC have indicated that obliga- 
members are also cell surface receptors of natriuretic tory in this activation process is an intervening step, 
factors. Two such guanylate cyclases have been charac- which is regulated by ATP [17,18]. ATP binding causes 
terized. One is the atria1 natriuretic factor (ANF) recep- an allosteric change in guanylate cyclase, bringing it to 
tor (ANF-RGC) [l-7], and the other is a receptor for the activated catalytic state. A defined ATP-regulated 
type C natriuretic peptide (CNP-RGC) [S]. ANF and module (ARM) of ANF-RGC with a sequence of 
CNP are structurally related peptide hormones that reg- GlyS03-Xa-Gly505-Xa-Xa-Xa-Gly5w is critical in ATP 
ulate hemodynamics of the physiological processes of binding and amplification of the hormonal signal [4,19]. 
diuresis, water balance, and blood pressure [&lo]; a CNP-RGC contains a structural motif (Gly499-Xa-Xa- 
third related hormone is the type B natriuretic peptide Xa-Gly503) which is shared by a section of the ANF- 
(BNP) [ll], but its receptor is not yet identified. One RGC ARM sequence. This raises an intriguing ques- 
important second messenger of these hormones is cyclic tion: is this the sequence through which ATP amplifies 
GMP (reviewed in [12-141). both ANF and CNP signals? 
ANF and CNP signal through their respective recep- 
tor guanylate cyclases, ANF-RGC and CNP-RGC. 
Both of these receptors show sequence similarity, and 
both contain a single membrane-spanning helical do- 
main which divides the protein into two roughly equal 
portions, the N-terminal extracellular and the C-termi- 
nal intracellular. The receptor domain lies in the ex- 
tracellular portion and the intracellular portion con- 
tains two domains, the one adjacent to the transmem- 
brane is termed ‘kinase-like’ domain due to its sequence 
similarity to the tyrosine kinase family, and the C-termi- 
nal region contains the catalytic domain [1,15]. In both 
proteins ligand binding to the extracellular eceptor do- 
If the answer is yes, it would indicate two things: (i) 
that this is the core ARM sequence which is critical in 
ATP binding and in amplification of the ANF signal; 
and (ii) that this core ARM sequence, in an identical 
fashion, amplifies the CNP signal. This will then pro- 
vide a unified mechanism by which ATP amplifies both 
ANF and CNP signals. The present study addresses 
these issues. 
2. MATERIALS AND METHODS 
The S-kDa CNP used in these studies was a 45 amino-acid peptide, 
Ser-Gln-Asp-Ser-Ala-Phe-Arg-Ile-Gln-Glu-Arg-Leu-Arg-Asn-Ser- 
Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-I~e- 
Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-~u-Arg-Leu-Phe; and 
ANF (rat, residues 8-33) was a 26 amino-acid peptide, Arg-Arg-Ser- 
Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-G~-Ser-G~y-~u- 
Gly-Cys-Asn-Ser-Phe-Arg-Tyr. These peptides were purchased from 
Peninsula Laboratories; GTP, cyclic GMP and bovine serum albumin 
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Fig. 1. Representation of GCa-Dmut (ANF-RGC) and CNP-RGC mutants. The mutated amino acid residues corresponding to the ARMS of 
ANF-RGC and CNP-RGC are indicated by shaded boxes. The appropriate changes in amino acid residues were created by site-directed mutagenesis 
as described in section 2. 
were from Sigma; ATPyS and ATP were from Boehringer- 
Mannheim; [‘2SI]NaI was from Amersham; cell culture media were 
from Gibco and restriction enzymes were purchased from USB and 
BioLabs. 
The CNP-RGC cDNA clone was isolated from a human retina 
cDNA library (Duda, T., Goraczniak, R., Sitaramayya, A. and 
Sharma, R.K., manuscript submitted); ANF-RGC (GCa-Dmut) was 
constructed from GCa cDNA as described previously [2]. Mutants 
corresponding to the ARM sequences of ANF-RGC and CNP-RGC 
were constructed as schematically represented in Fig. 1 and are de- 
scribed below. 
2.1. GCa-DmutLedo3Ser’07 (GCa-DmutlCNP-RGC ARM) 
The 1.9 kb SalI-XbaI fragment of GCa cDNA was subcloned into 
the pSelect-1 vector; Gly”’ was changed to Leu and Asn”” to Ser, 
using the mutagenic primer Y-CAGGGAGCCATAACTG- 
GAGCCTCGCAGACTCAGGGTCAG-3’, and the selection-ampi- 
cillin-repair primer (Promega mutagenesis kit). The EcoRV-XbaI 
fragments of GCa-Dmut cDNA in the pBluescript vector were re- 
placed with the EcoRV-XbaI fragment excised from a pselect-cDNA 
recombinant. 
2.2. CNP-RGCAla’q9 
Mutagenesis leading to the change of Gly4@ into Ala was performed 
on the 1.85 kb Sun-XbnI fragment of CNP-RGC cDNA subcloned 
into pselect-1 vector using mutagemc, S’-GCCGTAACTG- 
GAGGCCCGCAGCGACAG-3’ and the selection-ampicillin-repair 
primers. The 0.7 kb EcoRV-XbuI fragment excised from pSelect-1 
cDNA recombinant replaced the EcoRV-XbaI fragment of CNP- 
RGC cDNA. 
All the mutated recombinants were sequenced [20] to confirm their 
identities and correct ligations. The mutated-GCa and CNP-RGC 
cDNAs were individually subcloned into the XhoI-SmuI site of the 
pSVL vector to create pSVL-mutated cDNA expression constructs. 
For expression studies, COS-7 cells (simian virus 40 (SV40)-trans- 
formed African green monkey kidney cells) were transfected with the 
expression vector by the calcium phosphate technique [21]; 60 h after 
transfection, cells were washed with 50 mM Tris-HCl (pH 7.5) 110 mM 
MgClz buffer, scraped into 2 ml of ice-cold buffer, homogenized, 
centrifuged for 15 min at 5,000 x g and washed with the same buffer. 
The pellet represented the crude membranes. In control experiments, 
the crude membranes prepared from cells transfected with the pSVL 
vector alone were used. The crude membranes were assayed for 
guanylate cyclase activity [6]. The ATP binding was assayed as in [19]. 
3. RESULTS AND DISCUSSION 
In the present study we have extended the genetic 
remodeling technique to determine the role of the ARM 
core structural motif Gly-Xa-Xa-Xa-Gly in ANF and 
CNP signaling. Previous studies with ANF-RGC have 
shown that ARM sequence GlySo3-Xa-GlySo5-Xa-Xa- 
Xa-Gly5W positioned at 40 amino acid residues distal to 
the last carboxy-terminal amino acid residue of the 
transmembrane domain is essential in the ATP-medi- 
ated occurrence that bridges the events of ANF binding 
and signal transduction [19]. The counterpart of this 
ANF-RGC ARM structural motif in CNP-RGC is 
Xa497-Xa-Gly499-Xa-Xa-Xa-Gly503. This indicates that 
there is a change in the sequence form - there being two 
glycine-surrounded domains (Glv-Xa-Gly-Xa-Xa-Xa- 
Gly) in ANF-RGC and only one (Glv-Xa-Xa-Xa- 
Gly) in CNP-RGC. 
To determine whether the CNP-RGC ARM sequence 
could substitute the ANF-RGC ARM sequence in ANF 
signaling, in the first step GCa was genetically tailored 
to create a mutant, GCa-Dmut, which is structurally 
and functionally identical to the cloned wild-type ANF- 
RGC [2]. In the second step, ARM sequence of the 
genetically constructed ANF-RGC - Gly503-Arg-Gly- 
Ser-Asn507-Tyr-Gly509 ~ was changed to that of the 
CNP-RGC ARM (GCa-DmutlCNP-RGC ARM mu- 
tant) - &-Arg-Gly-Ser-Ser-Tyr-Gly - i.e. Gly503 was 
converted to Leu and Asn=to Ser (Fig. 1). The coding 
sequence of the mutated protein was introduced into an 
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Fig. 2. Effect of ATP (or ATPyS) and ANF on guanylate cyclase activity. Membranes of Cos7 cells transfected with GCa-DmutLeu5’%e?” 
(GCa-Dmut/CNP-RGC ARM), as described in section 2, were assayed for guanylate cyclase activity using Mg*+ as a cofactor [IS] in the presence 
of (A) ANF (0.1 PM) with indicated additions of ATP (or ATPyS) and (B) in the presence of 0.8 mM ATP with varied additions of ANF. The 
experiments were done in triplicate and repeated three times, although the data depicted are from one typical experiment; means f SD. are shown. 
expression vector, pSVL, under the transcriptional con- 
trol of the SV40 late promoter, which was then used to 
transfect COS-7 cells. The particulate fractions of these 
cells were appropriately treated and analyzed for the 
cyclase and ATP-binding activities. 
Because earlier studies with ANF-RGC have indi- 
cated that maximal guanylate cyclase activity is attained 
with 0.1 ,uM ANF in the presence of 800pM ATP [4,18], 
we first used the same concentrations of the above rea- 
gents to assess the basal and the ANF-stimulated 
cyclase activities of the mutated protein. The plasma 
membranes containing the mutated-protein showed 30- 
to 40-fold higher basal activity than the membranes of 
control cells transfected with pSVL alone (Table I), in- 
dicating that the encoded protein is a guanylate cyclase. 
To determine the role of CNP-RGC ARM sequence 
in ATP-mediated ANF signaling, the membranes of the 
transfected cells were incubated with a series of concen- 
trations of ATP, or ATPyS, in the presence of ANF (0.1 
yM). Both ATP and ATPyS stimulated the cyclase ac- 
tivity in a dose-dependent fashion; the maximal activity 
was observed at -800 yM and the half-maximal activa- 
tion (EC,) occurred between 300 and 400 ,uM (Fig. 2A). 
Neither ATP nor its non-hydrolyzable analog, 
ATPyS, by itself altered the basal cyclase activity of the 
CNP-RGC ARM-mutant; similarly, ANF alone had 
only marginal effect on the basal cyclase activity (Table 
I). 
To determine the kinetics of ANF-dependent activa- 
tion of guanylate cyclase, membranes of the cells trans- 
fected with GCa-DmutKNP-RGC ARM mutant 
cDNA were incubated with different concentrations of 
Table I 
Guanylate cyclase activity in membranes of transfected COS-7 cells 
Guanylate cyclase activity 
(pmol cyclic GMP/min/mg protein) 
Transfection Basal +ANF (lo-’ M) +CNP (lo-’ M) +ATP (0.8 mM) +ATPrS (0.8 mM) 
pSVL (control) -0.1 -0.1 -0.1 -0.1 -0.1 
GCa-Dmut 7.0 + 1.0 17.0 f 2.1 8.0 + 0.9 7.0 f 1.0 7.0 f 0.9 
GCcz-DmutValSo5Asn5” 5.0 f 0.4 9.1 + 1.0 5.4 f 0.6 5.1 + 0.6 5.2 + 0.6 
GCa-DmutLeu5’%er”” 8.1 I!I 0.5 18.0 + 1.2 9.2 + 1.1 9.1 f 1.0 8.9 f 0.9 
CNP-RGC 12.1 f 0.9 12.5 f 1.0 15.0 f 1.5 12.0 + 1.5 12.2 f 1.3 
CNP-RGCAla499 15.4 I! 1.0 14.0 ?I 1.5 13.5 + 1.5 14.0 f 1.5 14.2 f 1.5 
COS-7 cells were transfected with appropriate GCar or CNP-RGC mutant cDNAs in a pSVL expression vector. Membranes were prepared as 
described in section 2, and guanylate cyclase activity was determined [18]. The experiments were done in triplicate and repeated three times, although 
the data given are from one typical experiment. 
145 
Volume 315, number 2 FEBS LETTERS January 1993 
160 
140 
120 
80 
i 
60 
I60 
- 140 
120 
100 
80 
- 60 
- 40 
- 20 
0.0 0.2 04 0.6 0.6 IO 1.2 10 9 8 7 6 
Nucleotlde [mM] CNP [-logM] 
Fig. 3. Effect of ATP (or ATPyS) and CNP on guanylate cyclase activity. Membranes ofCos7 cells transfected with CNP-RGC or CNP-RGCAla499, 
as described in section 2, were assayed for guanylate cyclase activity using Mg2+ as a cofactor [18] in the presence of (A) CNP (0.1 PM) with indicated 
additions of ATP (or ATPyS) and (B) in the presence of 0.8 mM ATP with varied addttions of CNP. The experiments were done in triplicate and 
repeated twice: means f SD. are shown. Solid and open circles represent the membranes expressing wild-type CNP-RGC and the squares represent 
the CNP-RGCAla”W mutant. 
ANF in the presence of saturating amounts of ATP (800 
PM). ANF stimulated the guanylate cyclase activity in 
a dose-dependent fashion (Fig. 2B); the EC,, concentra- 
tion was 5 nM, an excess of threefold stimulation oc- 
curring well below lo-” M (Fig. 2B). 
To verify that the glycine cluster sequence Gly-Xa- 
Xa-Xa-Gly is directly involved in the ATP effect, the 
GCa-DmutlCNP-RGC ARM mutant was scrutinized 
for its ATP-binding activity. Comparison of [E-~~P]ATP 
binding by membranes expressing the Gly-Xa-Xa-Xa- 
Gly sequence with those expressing the disrupted 
glycine sequence mutant, Gly-Xa-Xa-Xa-Xa-Xa-Gly 
(GCa-DmutValSo5,Asn506, [ 19]), showed that the GCa- 
Dmut/CNP-RGC ARM mutant had over 2-fold higher 
Table II 
ATP binding to membranes of transfected COS-7 cells 
Transfectton Specific ATP bindmg 
(cpm/mg protem) 
pSVL (control) 30.314 + 500 
GCa-Dmut 106,930 f 1,900 
GCa-DmutVa15”AsnSDb 48,833 + 1.150 
GCa-DmutLeu503Ser5”7 102,717 k 1,200 
CNP-RGC 111.021 f 1.500 
CNP-RGCAla499 47,078 f 950 
Membranes of COS-7 cells were incubated m a total volume of 100 
~1 with [a-“P]ATP (6 x lo5 cpm/tube; spectfic activity 3.000 Ct/mmol) 
in the presence of 4 mM Mg’+ at room temperature for 10 min. The 
membranes were filtered through GFK filters and washed four times 
with ice-cold phosphate-buffered saline, pH 7.5. Non-specific binding 
was measured in the presence of 1 mM ATP. Specific binding was 
calculated by subtracting the non-specific radioactivtty bound to the 
filters. Values are means of duplicate determinations. Experiments 
were repeated twice, and the values were normahzed to depict a typical 
experiment. 
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ATP-binding activity than the glycine-disrupted mutant 
(Table II). 
These results are virtually identical to those previ- 
ously reported for the ANF-RGC which contains the 
wild-type ARM sequence [19], indicating that the CNP- 
RGC ARM sequence form, Gly-Xa-Xa-Xa-Gly, is able 
to effectively substitute the ANF-RGC ARM sequence 
and that the presence of both ATP and ANF is required 
for ANF signaling. These findings also indicate that in 
the originally identified ANF-RGC ARM sequence, 
Gly503-Xa-~505-Ser-Xa-Tyr-G&5W [2], the residues 
Gly503-Xa- constituting the first glycine domain (Glyso3- 
Xa-Gly505) are non-essential in ANF signaling, and sug- 
gest that the second glycine cluster sequence Glysos- 
Ser-Xa-Tyr-Gly509 meets the requirement of being the 
ATP regulatory module of guanylate cyclase that is 
critical in both binding and potentiating the ATP-medi- 
ated ANF signaling event. 
These results emphasizing the importance of core 
ARM sequence in ANF signaling raise a related ques- 
tion: could this sequence form - Gly499-Xa-Xa-Xa- 
Gly503 - also bridge the CNP-binding and catalytic 
guanylate cyclase signal transduction events? 
To answer this question, ATP studies were conducted 
with CNP-RGC and its mutant in which the glycine 
cluster was disrupted by changing the Gly499-Xa-Xa- 
Xa-Gly5”3 sequence to Ala499-Xa-Xa-Xa-Gly503, i.e. 
G1y499 was changed to Ala by site-directed mutagenesis. 
Ala was the choice amino acid because both Ala and 
Gly are neutral and similar in size and thus the substitu- 
tion in these amino acids would cause minimum devia- 
tion in the tertiary structure of the protein (Fig. 1). The 
coding sequences of CNP-RGC and the mutated pro- 
tein were introduced into expression vectors. which 
were then used to transfect he COS-7 cells (vide supra). 
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The particulate fractions of these cells were appropri- 
ately treated and analyzed for the cyciase and ATP- 
binding activities. 
The plasma membranes of the wild-type CNP-RGC 
cells (a) showed go-fold higher basal activity than the 
membranes of cells transfected with pSVL alone, de- 
monstrating that the encoded protein is a guanylate 
cyclase (Table I); (b) did not respond to either ATP (800 
PM) or CNP (0.1 ,uM) alone in stimulating the basal 
cyclase activity, indicating that these agents by them- 
selves are unable to potentiate the cyclase activity 
(Table I); (c) in the presence of saturating amounts of 
CNP (0.1 PM), responded to ATP (or ATPyS) stimula- 
tion of guanylate cyclase activity in a dose-dependent 
fashion with the maximal cyclase response occurring at 
-800 c(M ATP and the half-maximal activation (EC,,) 
at -500 ,uM ATP (Fig. 3A); (d) in the presence of ATP 
(800 PM), showed a dose-dependent stimulation of 
guanylate cyclase activity by CNP, the EC& concentra- 
tion was below 5 nM, an excess of twofold stimulation 
occurring well below lo-” M, and a 14-fold cyclase 
stimulation occurring at 0.1 yM CNP (Fig. 3B), and 
under identical conditions, ANF had no effect on CNP 
signaling. 
In contrast to the above results, the CNP-RGC-mu- 
tant with the disrupted glycine cluster did not signifi- 
cantly respond in its cyclase activity to any tested con- 
centration of ATP (or ATPyS) in the presence of satu- 
rating amounts of CNP (Fig. 3A) and, likewise, showed 
no stimulation of cyclase activity in response to the 
CNP concentrations up to 0.1 PM (Fig. 3B). The basal 
cyclase activity of both the wild type and the mutant 
were almost the same, however. This finding establishes 
the obligatory role of glycine cluster sequence Gly499- 
Xa-Xa-Xa-Glyso3 in ATP-regulated CNP signaling. 
This sequence, however, has no effect on the basal 
cyclase activity. 
To verify the role of the glycine cluster sequence in 
defining the ATP-binding site, the wild-type CNP-RGC 
and its mutant were scrutinized for their ATP binding 
activities (Table II). The wild-type receptor showed al- 
most 4-fold higher binding activity over the control cells 
expressing the pSVL expression vector, but the mutant 
with the disrupted glycine cluster had only marginally 
higher ATP binding activity above the control cells, 
These results prove that the sequence Gly499-Xa-Xa-Xa- 
Glyso3 of CNP-RGC is critical in both ATP binding and 
potentiating the cyclase activity. This sequence, there- 
fore, defines the ATP-regulatory module (ARM) of 
CNP-RGC, which bridges the steps of ligand binding 
and signal transduction. 
These studies do not prove that the Gly-Xa-Xa-Xa- 
Gly motif is the direct ATP binding site. But a ‘pre- 
dicted nucleotide-binding protein model’ indicates that 
the second glycine in the structural motif Gly-Xa-Gly- 
Xa-Xa-Gly is crucial in the direct GTP binding to the 
p21 protein [22]. This suggests a parallel between the 
structural motifs of GTP-binding proteins and the ATP- 
binding receptor guanylate cyclases. It is, therefore, a 
good possibility that the middle glycine in the ARM 
sequence - Gly-Xa-Cly-Xa-Xa-Gly - is the direct bind- 
ing site of ATP. As has been suggested for the ‘nucleo- 
tide-binding protein model’ 1221, it does not mean that 
the modification of the middle glycine will result in the 
complete elimination of the nucleotide binding to the 
protein. Such a change may merely result in the ‘altered 
mode of binding of the nucleotide’ [22]. This interpreta- 
tion fits our findings where we observe that disruption 
of the middle glycine cluster does not result in the com- 
plete elimination of ATP binding with the ANF-RGC 
and CNP-RGC mutants (Table II}. 
In conclusion, we have identified the core ARM se- 
quence of ANF-RGC and CNP-RGC that is essential 
in the ATP binding and the ANF-dependent and CNP- 
dependent cyclase activities. This finding provides a 
unified mechanism for the operation of both ANF and 
CNP signaling processes, and supports the multi-mod- 
ule concept of guanylate cyclase transduction system 
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